Hemp Enforcement, Modernization, and Protection Act

Issues related to cannabis clemency. MARIJUANA OPPORTUNITY REINVESTMENT AND EXPUNGEMENT ACT (MORE) - H.R. 5068 - federally decriminalize cannabis by removing (descheduling) marijuana from the Controlled Substances Act, which would remove federal criminal penalties for its manufacture, distribution, or possession. STRENGTHENING THE TENTH AMENDMENT THROUGH ENTRUSTING STATES ACT (STATES 2.0) - H.R. 2934 - aligning federal law with state cannabis policies by exempting cannabis produced and sold in compliance with state law from the federal definition of "marijuana." PREPARING REGULATORS EFFECTIVELY FOR A POST-PROHIBITION ADULT-USE REGULATED ENVIRONMENT ACT (PREPARE) - H.R. 2935 - S. 3576 - directing the Department of Justice to establish the Commission on the Federal Regulation of Cannabis to study a plausible and prompt pathway to cannabis regulation. EVIDENCE-BASED DRUG POLICY ACT - H.R. 3082 - repealing CSA restrictions on the Office of National Drug Control Policy (ONDCP) regarding the conducting of studies related to the legalization of a Schedule I substance. CLEAN SLATE ACT - H.R. 3114 - S. 1580 - sealing certain federal marijuana offenses and other certain nonviolent crimes after those with previous convictions after the completion of a sentence. MARIJUANA IN FEDERALLY ASSISTED HOUSING PARITY ACT - H.R. 6807 - S. 3537 - prohibiting the denial of occupancy of federally assisted housing on the basis of using, distributing, possessing, selling, or manufacturing marijuana in compliance with state law CANNABINOID SAFETY AND REGULATION ACT - S. 3474 - create a federal regulatory system for cannabinoid products (including hemp-derived consumer products). HEMP ENFORCEMENT MODERNIZATION, AND PROTECTION (HEMP) ACT - H.R. 7212 - establishing a nationwide age limit of 21 to purchase hemp-derived products. HEMP SAFETY ENFORCEMENT ACT - S. 4315 - permitting states and Indian tribes to opt out of the federal hemp production plan and new federal definition of hemp that would ban most hemp-derived THC products. AMERICAN HEMP PROTECTION ACT - H.R. 6209 - repealing the legislation set to take effect in November 2026 which would ban most hemp-derived THC products. HEMP PLANTING PREDICTABILITY ACT - H.R. 7024 - S. 3686 - postponing the effective date of the hemp ban by two years, from Nov. 12, 2026 to Nov. 12, 2028. It contains no additional regulatory provisions. The End Needless Distribution of 7-OH Act (H.R. 8000): restricting the distribution of synthetic 7-OH products by treating them as federally controlled substance with no accepted medical use. (OPPOSED)

Client expense: Not reported · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

HR 7212 To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes. H.R.9830 - Lawful Hemp Protection Act.

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues pertaining to the regulation of hemp products; S.3474, Cannabinoid Safety and Regulation Act; H.R.7567, Farm, Food, and National Security Act of 2026; S.5526, Agricultural Act of 2026; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; H.R.7024/S.3686, Hemp Planting Predictability Act; H.R.10079, Beverage Regulatory Parity Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Monitor the following: Public Law 119-75, Consolidated Appropriations Act, 2026, Division B - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Implementation of provisions relating to NIH, Substance use research and indirect costs H.R.9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027, Provisions relating to NIH, Substance use research, indirect costs and Multi-year funding related issues H.R.7212, To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes, Entirety Public Law 119-26, HALT Fentanyl Act, Drug use research related issues Synthetic Fentanyl related issues Barriers to research resulting from DEA scheduling, Drug research related issues H.R.1802, Safeguard Pets, Animals, and Research Ethics (SPARE) Act , Entirety

Client expense: Not reported · Firm income: $20,000

S.2451 - Hemp Access and Consumer Safety Act; All provisions H.R.7024 / S.3686 - Hemp Planting Predictability Act; All provisions H.R.7212 - Hemp Enforcement, Modernization, and Protection (HEMP) Act; All provisions S.4045 / H.R.8046 - Food and Nutrition Delivery Safety Act; All Provisions H.R.7469 - SNAP Online Access Act of 2026; All provisions

Client expense: $750,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 7212 To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes.

Client expense: Not reported · Firm income: $80,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

Issues related to cannabis clemency. MARIJUANA OPPORTUNITY REINVESTMENT AND EXPUNGEMENT ACT (MORE) - H.R. 5068 - federally decriminalize cannabis by removing (descheduling) marijuana from the Controlled Substances Act, which would remove federal criminal penalties for its manufacture, distribution, or possession. STRENGTHENING THE TENTH AMENDMENT THROUGH ENTRUSTING STATES ACT (STATES 2.0) - H.R. 2934 - aligning federal law with state cannabis policies by exempting cannabis produced and sold in compliance with state law from the federal definition of "marijuana." PREPARING REGULATORS EFFECTIVELY FOR A POST-PROHIBITION ADULT-USE REGULATED ENVIRONMENT ACT (PREPARE) - H.R. 2935 - S. 3576 - directing the Department of Justice to establish the Commission on the Federal Regulation of Cannabis to study a plausible and prompt pathway to cannabis regulation. EVIDENCE-BASED DRUG POLICY ACT - H.R. 3082 - repealing CSA restrictions on the Office of National Drug Control Policy (ONDCP) regarding the conducting of studies related to the legalization of a Schedule I substance. CLEAN SLATE ACT - H.R. 3114 - S. 1580 - sealing certain federal marijuana offenses and other certain nonviolent crimes after those with previous convictions after the completion of a sentence. MARIJUANA IN FEDERALLY ASSISTED HOUSING PARITY ACT - H.R. 6807 - S. 3537 - prohibiting the denial of occupancy of federally assisted housing on the basis of using, distributing, possessing, selling, or manufacturing marijuana in compliance with state law CANNABINOID SAFETY AND REGULATION ACT - S. 3474 - create a federal regulatory system for cannabinoid products (including hemp-derived consumer products). HEMP ENFORCEMENT MODERNIZATION, AND PROTECTION (HEMP) ACT - H.R. 7212 - establishing a nationwide age limit of 21 to purchase hemp-derived products. HEMP SAFETY ENFORCEMENT ACT - S. 4315 - permitting states and Indian tribes to opt out of the federal hemp production plan and new federal definition of hemp that would ban most hemp-derived THC products. AMERICAN HEMP PROTECTION ACT - H.R. 6209 - repealing the legislation set to take effect in November 2026 which would ban most hemp-derived THC products. HEMP PLANTING PREDICTABILITY ACT - H.R. 7024 - S. 3686 - postponing the effective date of the hemp ban by two years, from Nov. 12, 2026 to Nov. 12, 2028. It contains no additional regulatory provisions. The End Needless Distribution of 7-OH Act (H.R. 8000): restricting the distribution of synthetic 7-OH products by treating them as federally controlled substance with no accepted medical use. (OPPOSED)

Issues related to the legal status and regulation of cannabis, including industrial hemp and its derivative products. Issues related to the U.S. Food and Drug Administration (FDA) and the regulatory oversight of cannabidiol (CBD) products. H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; section 762, section 759 S. 2256 -Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; section 759, section 738 H.R.7212 - Hemp Enforcement, Modernization, and Protection Act H.R.7567 - Farm, Food, and National Security Act of 2026

Client expense: $530,000 · Firm income: Not reported

Government targets: Alcohol & Tobacco Tax & Trade Bureau (TTB), HOUSE OF REPRESENTATIVES, SENATE

Issues pertaining to the regulation of hemp products; S.3474, Cannabinoid Safety and Regulation Act; H.R.7567, Farm, Food, and National Security Act of 2026; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; H.R.7024/S.3686, Hemp Planting Predictability Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474, Cannabinoid Safety and Regulation Act (CSRA); draft Lawful Hemp Protection Act

Client expense: Not reported · Firm income: $40,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

Public Law 119-75, Consolidated Appropriations Act, 2026, Division B - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Implementation of provisions relating to NIH, Substance use research and indirect costs H.R.9260, Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027, Provisions relating to NIH, Substance use research, indirect costs and Multi-year funding related issues Monitor the following: H.R.7212, To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes, Entirety Public Law 119-26, HALT Fentanyl Act, Drug use research related issues Synthetic Fentanyl related issues Barriers to research resulting from DEA scheduling, Drug research related issues H.R.1802, Safeguard Pets, Animals, and Research Ethics (SPARE) Act , Entirety

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE

Issues related to closing the 2018 Farm Bill hemp loophole; H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026 S. 2256 -Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; and Hemp Enforcement, Modernization, and Protection (HEMP) Act (H.R. 7212) under the AGR code.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

Low-dose hemp-derived cannabinoid regulation; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; S.3474,Cannabinoid Safety and Regulation Act (CSRA)

Client expense: Not reported · Firm income: $40,000

Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE

S.2451 - Hemp Access and Consumer Safety Act; All provisions H.R.7024 / S.3686 - Hemp Planting Predictability Act; All provisions H.R.7212 - Hemp Enforcement, Modernization, and Protection (HEMP) Act; All provisions S.4045 / H.R.8046 - Food and Nutrition Delivery Safety Act; All Provisions H.R.7469 - SNAP Online Access Act of 2026; All provisions

Client expense: $690,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Issues pertaining to the regulation of hemp products; S.3474, Cannabinoid Safety and Regulation Act; H.R.7567, Farm, Food, and National Security Act of 2026; H.R.7212, Hemp Enforcement, Modernization, and Protection (HEMP) Act; H.R.7024/S.3686, Hemp Planting Predictability Act.

Client expense: Not reported · Firm income: $50,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

Issues related to the legal status and regulation of cannabis, including industrial hemp and its derivative products. Issues related to the U.S. Food and Drug Administration (FDA) and the regulatory oversight of cannabidiol (CBD) products. H.R. 4121 - Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; section 762, section 759 S. 2256 -Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, 2026; section 759, section 738 H.R.7212 - Hemp Enforcement, Modernization, and Protection Act

Client expense: $320,000 · Firm income: Not reported

Government targets: Alcohol & Tobacco Tax & Trade Bureau (TTB), HOUSE OF REPRESENTATIVES, SENATE

HR 7212 To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE, White House Office

Public Law 119-75, Consolidated Appropriations Act, 2026, Division B - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2026, Provisions relating to NIH, Substance use research and indirect costs Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027, Provisions relating to NIH, Substance use research, indirect costs and Multi-year funding related issues H.R.7212, To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of cannabinoid hemp products, and for other purposes, Entirety Public Law 119-26, HALT Fentanyl Act, Drug use research related issues Synthetic Fentanyl related issues Barriers to research resulting from DEA scheduling, Drug research related issues H.R.1802, Safeguard Pets, Animals, and Research Ethics (SPARE) Act , Entirety

Client expense: Not reported · Firm income: $20,000

Government targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE